Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther. 2008; 10(5):R109.
-
Adult
-
Adult
-
Aged
-
Aged
-
Aged, 80 and over
-
Aged, 80 and over
-
Antibodies, Antinuclear
-
Antibodies, Antinuclear
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Humanized
-
B-Cell Activating Factor
-
B-Cell Activating Factor
-
B-Lymphocytes
-
B-Lymphocytes
-
Double-Blind Method
-
Double-Blind Method
-
Enzyme-Linked Immunosorbent Assay
-
Enzyme-Linked Immunosorbent Assay
-
Female
-
Female
-
Humans
-
Humans
-
Lupus Erythematosus, Systemic
-
Lupus Erythematosus, Systemic
-
Male
-
Male
-
Middle Aged
-
Middle Aged